Fumaric Acid

Fumaric Acid

SCHEMBL7820760

O=C(O)C=CC(=O)O.c1csc(CCCSc2nsnc2C2CN3CCC2CC3)c1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 3/20 0.44
CHRM3 known ✓ P20309 2/20 0.40
CHRM1 P11229 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7820759 1.00 CHRM2 (0.44) CHRM2CHRM1CHRM3
SCHEMBL7818023 0.92 CHRM2 (0.48) CHRM2
Oxalic Acid SCHEMBL7821928 0.89 CHRM2 (0.52) CHRM2CHRM1
Fumaric Acid SCHEMBL7820915 0.87 CHRM2 (0.51) CHRM2CHRM1
Fumaric Acid SCHEMBL7820911 0.87 CHRM2 (0.51) CHRM2CHRM1
SCHEMBL7818869 0.87 CHRM2 (0.54) CHRM2CHRM1
Oxalic Acid SCHEMBL7953188 0.85 CHRM1 (0.54) CHRM2CHRM1
Oxalic Acid SCHEMBL7810636 0.85 CHRM1 (0.54) CHRM2CHRM1
Fumaric Acid SCHEMBL7817500 0.84 CHRM2 (0.50) CHRM2CHRM1CHRM3
Fumaric Acid SCHEMBL7817497 0.84 CHRM2 (0.50) CHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281233-B1 AZABICYCLIC RING-SUBSTITUTED THIA- OR OXADIAZOLES NOVO NORDISK A/S (DK) 2001-08-28 US disclosed
US-6281232-B1 AZABICYCLIC RING-SUBSTITUTED THIA- OR OXADIAZOLES NOVO NORDISK A/S (DK) 2001-08-28 US disclosed
US-6271229-B1 ADMINISTERING A 1,2,5-OXADIAZOLE COMPOUND OR 1,2,5-THIADIAZOLE COMPOUND NOVO NORDISK A/S (DK) 2001-08-07 US disclosed
US-6265419-B1 IRRITABLE BOWEL DISORDER NOVO NORDISK A/S (DK) 2001-07-24 US disclosed
EP-0714394-B1 ANTIPSYCHOTIC METHOD WITH THIADIAZOLE AND OXADIAZOLE DERIVATIVES NOVO NORDISK AS (DK) 2001-06-20 EP disclosed
US-5968926-A SCHIZOPHRENIA TREATMENT WITH 1,2,5-OXADIAZOLE OR 1,2,5-THIADIAZOLE NOVO NORDISK A/S (DK) 1999-10-19 US disclosed
EP-0687266-B1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK AS (DK) 1998-11-11 EP disclosed
US-5663182-A ADMINISTERING AN AZABICYCLIC RING SUBSTITUTED THIADIAZOLE OR OXADIAZOLE TO A MAMMAL BYMASTER FRANKLIN PORTER (US) 1997-09-02 US disclosed
US-5612351-A AZABICYCLIC DERIVATIVES OF 1,2,3-OXA(OR THIA)DIAZOLE NOVO NORDISK A/S (DK) 1997-03-18 US disclosed
US-5578602-A FOR STIMULATING COGNITIVE FUNCTIONS OF THE BRAIN, TREATING ALZHEIMER*S DISEASE, GLAUCOMA OR PAIN NOVO NORDISK A/S (DK) 1996-11-26 US disclosed
US-5527813-A THERAPEUTICALLY ACTIVE AZABICYCLIC COMPOUNDS USEFUL AS STIMULANTS OF THE COGNITIVE FUNCTION OF THE FOREBRAIN AND IN THE TREATMENT OF ALZHEIMER'S DISEASE NOVO NORDISK A/S (DK) 1996-06-18 US disclosed
EP-0714394-A1 ANTIPSYCHOTIC METHOD NOVO NORDISK A/S (DK) 1996-06-05 EP disclosed
EP-0687266-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1995-12-20 EP disclosed
WO-1995005379-A1 ANTIPSYCHOTIC METHOD NOVO NORDISK A/S (DK) 1995-02-23 WO disclosed
WO-1994020496-A1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1994-09-15 WO disclosed